TELA TELA Bio Inc

Price (delayed)

$1.3

Market cap

$58.36M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.77

Enterprise value

$83.82M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 22

TELA Bio, Inc. is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The ...

Highlights
TELA Bio's EPS has increased by 27% YoY and by 2.5% from the previous quarter
TELA Bio's gross profit has increased by 7% YoY
TELA Bio's debt has increased by 36% YoY
The quick ratio is down by 21% since the previous quarter and by 9% year-on-year

Key stats

What are the main financial stats of TELA

TELA stock price

How has the TELA Bio stock price performed over time
Intraday
-7.8%
1 week
10.17%
1 month
101.14%
1 year
-15.58%
YTD
10.17%
QTD
73.33%

Financial performance

How have TELA Bio's revenue and profit performed over time
Revenue
$79.91M
Gross profit
$54.19M
Operating income
-$34.01M
Net income
-$41.18M
Gross margin
67.8%
Net margin
-51.5%
The operating margin has grown by 14% YoY
The operating income has increased by 9% year-on-year
TELA Bio's gross profit has increased by 7% YoY
TELA's revenue is up by 6% year-on-year

Price vs fundamentals

How does TELA's price correlate with its fundamentals

Growth

What is TELA Bio's growth rate over time

Valuation

What is TELA Bio stock price valuation
P/E
N/A
P/B
N/A
P/S
0.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.05
TELA Bio's EPS has increased by 27% YoY and by 2.5% from the previous quarter
TELA's price to sales (P/S) is 68% more than its last 4 quarters average of 0.6 but 64% less than its 5-year quarterly average of 2.8
TELA's revenue is up by 6% year-on-year

Efficiency

How efficient is TELA Bio business performance
TELA's ROIC is up by 16% YoY and by 3.8% QoQ
TELA Bio's ROS has increased by 11% YoY but it has decreased by 2.4% from the previous quarter
TELA's ROA is down by 6% since the previous quarter and by 5% year-on-year

Dividends

What is TELA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TELA.

Financial health

How did TELA Bio financials performed over time
TELA's total assets is 21% less than its total liabilities
The total liabilities has grown by 30% YoY
The quick ratio is down by 21% since the previous quarter and by 9% year-on-year
TELA Bio's debt to equity has shrunk by 178% YoY but it has surged by 67% QoQ
TELA Bio's debt has increased by 36% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.